Air Liquide plans to invest over $160 million in new capacity and upgrades to support a long-term agreement under which the company will supply additional gaseous oxygen, nitrogen and syngas to Eastman Chemical’s Longview, Texas, facility.
The project includes construction of a new air separation unit (ASU) and a partial oxidation unit (POX), both slated for startup in late 2021.
The new POX, which will employ Air Liquide’s patented Lurgi technology syngas, will capture and recycle carbon dioxide. Eastman uses syngas at Longview as a feedstock for the production of propionaldehyde, isobutanol, n-butanol, and 2-ethylhexanol (2-EH).
“This project and supply agreement reflect Eastman’s focus to invest in growth opportunities through strategic partnerships to create positive economic and environmental benefits,” says Mark Costa, Eastman’s chairman and CEO.
By: Clay Boswell
Source: Chemical Week
This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.
Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.
